Rociletinib
Product Specifications
CAS Number
1374640-70-6
Target
EGFR
Related Pathways
Angiogenesis, JAK/STAT signaling, Tyrosine Kinase/Adaptors
Purity
0.9925
Bioactivity
Rociletinib (CNX-419) is an orally available small molecule, irreversible inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
Smiles
COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O
Molecular Formula
C27H28F3N7O3
Molecular Weight
555.55
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx306357-01 20 µg
ATP Synthase Subunit E, Mitochondrial (ATP5ME) Antibody (HRP)
Sign In for Pricing
View Details abx306357-02 50 µg
ATP Synthase Subunit E, Mitochondrial (ATP5ME) Antibody (HRP)
Sign In for Pricing
View Details abx306357-03 100 µg
ATP Synthase Subunit E, Mitochondrial (ATP5ME) Antibody (HRP)
Sign In for Pricing
View Details abx306357-04 200 µg
ATP Synthase Subunit E, Mitochondrial (ATP5ME) Antibody (HRP)
Sign In for Pricing
View Details abx306357-05 1 mg
ATP Synthase Subunit E, Mitochondrial (ATP5ME) Antibody (HRP)
Sign In for Pricing
View Details MBS1136722-01 0.02 mg (E-Coli)
Recombinant Human Surfeit locus protein 6 (SURF6)
Sign In for Pricing
View Details